Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 74 Prostatic Neoplasms 54 Breast Neoplasms 15 Neoplasms 11 Sarcoma 10 Endometrial Neoplasms 10 Vaginal Neoplasms 8 Esophageal Neoplasms 6 Uterine Neoplasms 5 Radiation Injuries 5 Lung Neoplasms 5 Liver Neoplasms 5 Vulvar Neoplasms 4 Glioblastoma 4 Carcinoma, Ductal, Breast 4 Adenocarcinoma 4 Retinoblastoma 3 Ovarian Neoplasms 3 Neuroectodermal Tumors, Primitive, Peripheral 3 Hyperthermia 3 Gliosarcoma 3 Desmoplastic Small Round Cell Tumor 3 Central Nervous System Neoplasms 3 Carcinoma, Intraductal, Noninfiltrating 3 Carcinoma, Hepatocellular 3 Breast Carcinoma In Situ 3 Brain Neoplasms 3 Uveal Melanoma 2 Rhabdomyosarcoma 2 Rectal Neoplasms 2

Interventions

Fluorouracil 9 Radiotherapy 7 Cisplatin 7 Radiotherapy, Intensity-Modulated 4 Mitomycin 4 Magnetic Resonance Spectroscopy 4 Specimen Handling 3 Radiation 3 Nivolumab 3 Capecitabine 3 dehydroftorafur 2 Taxes 2 Paclitaxel 2 Cetuximab 2 Carboplatin 2 Biopsy 2 toripalimab 1 rocakinogene sifuplasmid 1 pembrolizumab 1 durvalumab 1 atezolizumab 1 X-Rays 1 Watchful Waiting 1 Vaccines 1 VGX-3100 1 Sigmoidoscopy 1 Radiosurgery 1 Proctoscopy 1 Platinum 1 Phantoms, Imaging 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Anal Canal Carcinoma × Brachytherapy × Clear all

NCT03465501 2018-03-14

BOOST-CA

Institut Paoli-Calmettes

Gastrointestinal

Anal Canal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡